Novartis
20 portfolio companies · 5 on the map · $1.8B raised · 5 cities
Portfolio map
5 Novartis portfolio companies on the map.
Portfolio companies
Intellia Therapeutics
Cambridge
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Biotechnology Research$1.7BEst. 2014
Lightship
Broomfield
Bringing recreational vehicles into the electric age
Motor Vehicle Manufacturing$61.2MEst. 2020
Octave
Mechelen
Mechelen-based · energy.
Energy$750KEst. 2020SiO2 Medical Products
Auburn
SiO2 Materials Science is a plastic container designing company.
Mekonos
San Francisco
Mekonos is a Silicon Valley Venture-backed Life Sciences company — creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in cell & gene therapies and cell line development.
BiotechnologySeries AEst. 2017
More portfolio companies
15 more Novartis investments we track beyond the map.
RocheBasel · Post-IPO Equity
YourBio HealthMedford · Series C
Dren BioFoster City · Corporate
Borealis BiosciencesVancouver · Series A
Koneksa HealthNew York · Series C
NuvoAirBoston · Series A
YseopParis · Venture
Molecular PartnersZürich · Post-IPO Equity
Proteus Digital HealthRedwood City · Series F
Dunad TherapeuticsLondon · Series A
IFM TherapeuticsBoston · Series A
Ayala PharmaceuticalsWilmington · Series B
Homology MedicinesLexington · Series B
Aduro BioTechBerkeley · Post-IPO Equity
ParrotsSeattle · Seed
Portfolio map
5 Novartis portfolio companies on the map.